Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy: Implications for a direct link between inflammation and carcinogenesis

American Journal of Therapeutics

Volumn 12, Issue 2, 2005, Pages 117-126

  Khatami, Mahin ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Allergy; Cancer; Goblet cells; Immune dysfunction; Inflammation; Lymphoid hyperplasia; Macrophages; Mast cells

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ALLERGY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; EXPERIMENTAL MODEL; GOBLET CELL; GUINEA PIG; HISTOPATHOLOGY; INFLAMMATION; LYMPHOID HYPERPLASIA; MACROPHAGE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; ANTIBODY FORMATION; CELL DEGRANULATION; CHRONIC DISEASE; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; DOGS; EPITHELIUM; GUINEA PIGS; HAPLORHINI; HYPERPLASIA; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION MEDIATORS; LYMPHOID TISSUE; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 17144394170     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000143699.91156.21     Document Type: Article

References (40)

1. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540-550.
2. Adelstein P, Baldwin JA, Fedrich J. Cancers of the large bowel: associated disorders in individuals. Cancer. 1979; 43:2553-2557.
3. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16:217-232.
4. Farrow B, Sugiyama Y, Chen A, et al. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg. 2004;239:763-771.
5. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003;5:46-62.
6. Vesterinen E, Oukkala E, Timonen T, et al. Cancer incidence among 78000 asthmatic patients. Int J Epidemiol. 1993;22:976-982.
7. Huovinen E, Kapiro J, Vesterinen E, et al. Mortality of adults with asthma: a prospective cohort study. Thorax. 1997;52:49-54.
8. Brightling CE, Bradding P, Pavord ID, et al. New insights into the role of the mast cell in asthma. Clin Exp Allergy. 2003;33:550-556.
9. Leonardi A, Jose PJ, Zhan H, et al. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology. 2003;110:487-492.
10. Kunert KS, Keane-Myers AM, Spurr-Michaul S, et al. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2001;42:2483-2489.
11. Khatami M, Donnelly JJ, John T, et al. Vernal conjunctivitis. Model studies in guinea pigs immunized topically with fluoresceinyl ovalbumin. Arch Ophthalmol. 1984;102: 1683-1688.
12. Tobin MJ. Chronic obstructive disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer. Am J Respir Crit Care Med. 2000;164: 1789.
13. Tomita M, Matsuzaki Y, Edagawa M, et al. Distribution of mast cells in mediastinal lymph nodes from lung cancer patients. World J Surg Oncol. 2003;1:25.
14. Heinz C, Fanihagh F, Steuhl KP. Squamous cell carcinoma of the conjunctiva in patients with atopic eczema. Cornea. 2003;22:135-137.
15. Hansen A, Gosemann M, Pruss A, et al. Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum. 2004;50:1897-1908.
16. Khatami M, Donnelly JJ, Rockey JH. Induction and down-regulation of conjunctival type-1 hypersensitivity reactions in guinea pigs sensitized topically with fluoresceinyl ovalbumin. Ophthalmic Res. 1985;17:139-147.
17. Donnelly JJ, Taylor JR, Young E, et al. Experimental ocular onchocerciasis in cynomolgus monkeys. Invest Ophthalmol Vis Sci. 1986;27:492-499.
18. Sakla AA, Donnelly JJ, Lok JB, et al. Punctate keratitis induced by subconjunctivally injection of Onchocerca linealis. Arch Ophthalmol. 1986;104:894-898.
19. Donnelly JJ, Sakla AA, Hill DE, et al. Effect of diethylcarbamazine citrate and anti-inflammatory drugs on experimental onchocercal punctate keratitis. Ophthalmic Res. 1987;19:129-134.
20. Donnelly JJ, Xi M-S, Haldar JP, et al. Autoantibody-induced by experimental Onchocerca infection. Effects of different routes of administration of microfilaria and of treatment with diethylcarbamazine citrate and ivermectin. Invest Ophthalmol Vis Sci. 1988;29:827-831.
21. Haldar JP, Khatami M, Donnelly JJ, et al. Experimental allergic conjunctivitis: production of different isotypes of antibody by conjunctival-associated lymphoid tissue in culture. Regul Immunol. 1988;1:92-999.
22. Khatami M, Donnelly JJ, Haldar JP, et al. Massive follicular lymphoid hyperplasia in experimental chronic recurrent allergic conjunctivitis: local antibody production. Arch Ophthalmol. 1989;107:433-438.
23. Haldar JP, Khatami M, Lok JB, et al. Experimental ocular onchocerciasis: local and systemic antibody and cell mediated immune responses. Trop Med Parasitol. 1990;41: 234-240.
24. Helleboid L, Khatami M, Wei Z-G, et al. Histamine and prostacyclin: primary and secondary release in allergic conjunctivitis. Invest Ophthalmol Vis Sci. 1991;31:2281-2289.
25. Rockey JH, Donnelly JJ, John T, et al. IgE antibodies in ocular immunopathology. In: O'Conner GR, Chandler JW, eds. Advances in Immunology and Immunopathology of the Eye. Masson Publishing. 1985:199-202.
26. Khatami M. Induction of conjunctival-associated lymphoid hyperplasia by antigen and tumor promoting agents. Targeting mediators of inflammatory responses as biomarkers for early detection of tumor/cancer. AACR: The Biology and Genetics of Early Detection and Chemoprevention of Cancer. Bal Harbour, FL, 1999 (abstr).
27. Khatami M. Inflammation-induced lymphoid hyperplasia: potential direct link between inflammation and tumorigenesis: inflammatory mediators as ideal biomarkers for early detection and prevention of tumors/cancers. 2nd International Conference on New Perspectives in the Treatment of Small Cell Lung Cancer, Lausanne, Switzerland, 2002 (abstr).
28. DiCarlo E, Forni G, Lollini PL, et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood. 2001;97:339-345.
29. Daly C, Dube C, Rollins BJ. Chemokine influences on adaptive immunity and malignancies of the immune system. Emst Schering Res Found Workshop. 2004;45:11-30.
30. Fendrick AM, Baldwin JL. Allergen-induced inflammation and the role of immunoglobulin E (IgE). Am J Ther. 2001;8:291-297.
31. Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer. 1999;26: 103-108.
32. Shakoory B, Fitzgerald SM, Lee SA, et al. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res. 2004;24:271-281.
33. Austen KF, Boyce JA. Mast cell lineage development and phenotypic regulation. Leuk Res. 2001;25:511-518.
34. Montovani A, Ming WJ, Balotta C, et al. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta. 1986;865:59-67.
35. Al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMs): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb. 2000;45: 1-16.
36. Suzuki M, Kobayashi H, Ohwada M, et al. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecol Oncol. 1998;68:35-37.
37. Mroczko B, Szmitkowski M, Okulczyk B. Granulocyte-colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med. 2002;40:351-355.
38. Henson DE, Albores-Saavedra J. eds. In: Pathology of Incipient Neoplasia, Oxford University Press. Third Edition, 2001.
39. Herendeen JL, Lindley C. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacol. 2003;37: 1664-1674.
40. Hahm KB, Song YJ, Oh TY, et al. Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J Biochem Mol Biol. 2003; 36:82-94.